Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT00457067
Brief Title:
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Official Title:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia With Neovascularization
Study:
NCT00457067
Protocol Section:
NCT00457067